COL17A1 and rheumatic disorder: Although it remains unclear whether collagen diseases are a risk factor for BP development, two studies explored preclinical anti-BP180 autoantibodies in a collagen disease population while evaluating the diagnostic performance of BP180 NC16A ELISAs (6, 16).